Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's

Go back to Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 208.46 -7.66 (3.54%)
Previous Close $216.12    52 Week High $333.65 
Open $215.95    52 Week Low $223.02 
Day High $215.95    P/E 26.69 
Day Low $208.27    EPS $7.81 
Volume 1,218,473